Cryoablation of Low Risk Breast Cancers less than 1.5 cm: An evaluation of local recurrence (Ice3 Trial)
A study for women with breast cancer using cryosurgery
Sponsor: IceCure Medical Ltd.
Enrolling: Female Patients Only
IRB Number: AAAQ7012
U.S. Govt. ID: NCT02200705
Contact: Margaret Chen-Seetoo: (212) 342-3681 / mc2978@cumc.columbia.edu
Additional Study Information: The purpose of this study is to find out whether a new kind of treatment, called cryoablation or cryosurgery, can be used together with certain kinds of imaging like ultrasound to effectively treat your cancer. Specifically, we are studying how effective cryoablation is in destroying your early stage breast cancer and preventing its recurrence or reappearance in the same breast. Cryoablation is a kind of treatment that uses a hollow, thin tube, called a cryoprobe, to kill your tumor by freezing it. The doctor will insert the cryoprobe like a needle into the tumor, centering the tumor in the middle of the cryoprobe's freeze zone. While the doctor is doing this, he or she is using a device called ultrasound, which bounces sound waves to create an image that the doctor sees on a screen. These ultrasound images will help the doctor to accurately guide the cryoprobe to the correct location of your breast.
This study is closed
Investigator
Margaret Chen-Seetoo, MD
Do You Qualify?
Have you been diagnosed with breast cancer? Yes No
Are you older than 65 years of age? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Margaret Chen-Seetoo
mc2978@cumc.columbia.edu
(212) 342-3681